The use of GnRH‐a too early after oocyte collection may delay subsequent treatment due to its “flare‐up effect,” which may increase the risk of ovarian hyperstimulation syndrome (OHSS), while the use of long‐acting GnRHa has recently been shown to reduce the incidence of OHSS [58]. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.